FOXP3 and diabetes mellitus: We observed an increased prevalence of Foxp3+ Tregs together with a decrease in TH1 cytokine levels in successfully-treated, diabetes-free mice, especially in PLN, when injected into the abdominal region overlying the expected location of the pancreas.